Nausea and Vomiting

Therapy of Digestive Disorders

Volumn , Issue , 2006, Pages 1003-1016

  Koch, Kenneth L ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34848878172     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-0317-5.50076-5     Document Type: Chapter

References (77)

1. Koch KL Approach to the patient with nausea and vomiting. Textbook of gastroenterology 1995, 731-749. JB Lippincott, Philadelphia, PA. 2nd edn. T. Yamada (Ed.).
2. Fischler B, Tack J, DeGucht V, et al. Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia. Gastroenterology 2003, 124:903-910.
3. Talley NJ, Stanghellini V, Heading RC, et al. Functional gastroduodenal disorders. Rome II: functional gastrointestinal disorders: diagnosis, pathophysiology, and treatment-a multinational consensus 2000, 299-350. Deganon Associates, McLean, VA. D.A. Drossman (Ed.).
4. Muth ER, Stern RM, Thayer JF, et al. Assessment of the multiple dimensions of nausea. The Nausea Profile (NP). J Psychosom Res 1996, 40:511-520.
5. Lang IM, Sarna SK, Condon RE Gastrointestinal motor correlates of vomiting in the dog: Quantification and characterization as an independent phenomenon. Gastroenterology 1986, 90:40.
6. Brzana RJ, Koch KL Gastroesophageal reflux disease presenting with intractable nausea. Ann Intern Med 1997, 126:704-707.
7. Geldorf H, Van Der Schee EJ, Smout AJPM, et al. Myoelectrical activity of the stomach in gastric ulcer patients: An electrogastrographic study. J Gastrointest Motil 1989, 1:122.
8. Kim TW, Beckett EAH, Hanna R, et al. Regulation of pacemaker frequency in the murine gastric antrum. J Physiol (London) 2002, 538:145-157.
9. Huisinga JD Physiology and pathophysiology of the interstitial cell of Cajal: From bench to bedside II. Gastric motility: lessons from mutant mice on slow waves and innervation. Am J Physiol 2001, 281:G1129-G1134.
10. He CL, Soffer EE, Ferris CD, et al. Loss of interstitial cells of Cajal and inhibitory innervation in insulin-dependent diabetes. Gastroenterology 2001, 121:427-434.
11. De Giorgio R, Guerrini S, Barbara G, et al. Inflammatory neuropathies of the enteric nervous system. Gastroenterology 2004, 126:1872-1883.
12. Thompson WG, Longstreth G, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Rome II: functional gastrointestinal disorders 2000, 351-397. Deganon Associates, McLean, VA. 2nd edn. D.A. Drossman (Ed.).
13. Hinder RA, Kelley KA Human gastric pacesetter potential: Sight of origin, spread, and response to gastric transection and of proximal vagotomy. Am J Surg 1997, 133:29-33.
14. Chen JDZ, Schirmer BD, McCallum RW Serosal and cutaneous recordings of gastric myoelectrical activity in patients with gastroparesis. Am J Physiol 1994, 266:G90-G98.
15. Koch KL, Stern RM Handbook of electrogastrography 2003, Oxford Press, New York.
16. Koch KL The stomach: electrogastrography. Atlas of gastrointestinal motility 2002, 185-201. BC Decker, Ontario, Canada. M. Schuster, M. Crowell, K.L. Koch (Eds.).
17. Stern RM, Koch KL, Stewart WR, et al. Spectral analysis of tachygastria recorded during motion sickness. Gastroenterology 1987, 92:92-97.
18. Koch KL, Xu L, Bingaman S, et al. Effects of ondansetron on morphine-induced nausea, vasopressin and gastric myoelectrical activity in healthy humans. Gastroenterology 1993, 104:A535.
19. Abell TM, Malagelada J-R Glucagon-evoked gastric dysrhythmias in humans shown by an improved electrogastrographic technique. Gastroenterology 1985, 88:1932-1940.
20. Hasler WL, Soudah HC, Dulai G, et al. Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins. Gastroenterology 1995, 108:727-736.
21. Koch KL, Stern RM, Vasey M, et al. Gastric dysrhythmias and nausea of pregnancy. Dig Dis Sci 1990, 35:961-968.
22. Koch KL, Stern RM, Stewart WR, et al. Gastric emptying and gastric myoelectrical activity in patients with symptomatic diabetic gastroparesis: Effect of long-term domperidone treatment. Am J Gastroenterol 1989, 84:1069-1075.
23. Bersherdas K, Leahy A, Mason I, et al. The effect of cisapride on dyspepsia symptoms and the electrogastrogram in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther 1998, 12:755-759.
24. Cucchiara S, Minella R, Riezzo G, et al. Reversal of gastric electrical dysrhythmias by cisapride in children with functional dyspepsia: report of three cases. Dig Dis Sci 1992, 37:1136-1140.
25. Rothstein RD, Alavai A, Reynolds JC Electrogastrography in patients with gastroparesis and effect of long-term cisapride. Dig Dis Sci 1993, 38:1518-1524.
26. Koch KL, Hong S-P, Xu L Reproducibility of gastric myoelectrical activity and the water load test in patients with dysmotility-like dyspepsia symptoms and in control subjects. J Clin Gastroenterol 2000, 31(2):125-129.
27. Stanghellini V, Tosetti C, Paternico A, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996, 110:1036-1042.
28. Brzana RJ, Bingaman S, Koch KL Gastric myoelectrical activity in patients with gastric outlet obstruction and idiopathic gastroparesis. Am J Gastroenterol 1998, 93:1083-1089.
29. Liberski SM, Koch KL, Atnip RG, et al. Ischemic gastroparesis: Resolution of nausea, vomiting and gastroparesis after mesenteric artery revascularization. Gastroenterology 1990, 99:252-257.
30. Koch KL, Stern RM, Vasey MW, et al. Neuroendocrine and gastric myoelectrical responses to illusory self-motion in man. Am J Physiol 1990, 258:E304-E310.
31. Uitjtdehaage SHJ, Stern RM, Koch KL Effects of eating on vection-induced motion sickness, cardiac vagal tone and gastric myoelectrical activity. Psychophysiology 1992, 29:193-201.
32. Lang IM, Sarna SK, Condon RE Gastrointestinal motor correlates of vomiting in the dog: Quantification and characterization as an independent phenomenon. Gastroenterology 1986, 90:40-47.
33. Lang IM, Sarna SK, Dodds WJ The pharyngeal, esophageal, and proximal gastric responses associated with vomiting. Am J Physiol 1993, 265:G963-G972.
34. Cubeddu LX, Hoffmann IS, Fuenmayor NT, et al. Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med 1990, 322:810.
35. Neilsen OH, Hvid-Jacobsen K, Lund P, et al. Gastric emptying and subjective symptoms of nausea: Lack of efforts of a 5-hydroxytryptamine, antagonist ondansetron on gastric emptying in patients with gastric stasis syndrome. Digestion 1990, 46:89.
36. Koch KL Gastroparesis. Neuro-gastroenterology 2004, 163-180. Elsevier, Philadelphia. E.M.M. Quigley, R.F. Pfeiffer (Eds.).
37. Camilleri M Disorders of gastrointestinal motility and neurological diseases. Mayo Clin Proc 1990, 65:825-846.
38. O'Brien MD, Bruce BK, Camilleri M The rumination syndrome: Clinical features other than manometric diagnosis. Gastroenterology 1995, 108:1024-1029.
39. Koch KL, Stern RM Functional disorders of the stomach. Sem Gastrointest Dis 1996, 4:185-195.
40. Talley NJ, Stanghellini V, Heading RC, et al. Functional gastroduodenal disorders. Gut 1999, 45(II):1137-1142.
41. Carnett JB Intercostal neuralgia as a cause of abdominal pain and tenderness. Surg Gynecol Obstet 1926, 12:625-635.
42. Van Der Voort IR, Osmanoglou E, Seybold M, et al. Electrogastrography as a diagnostic tool for delayed gastric emptying in functional dyspepsia and irritable bowel syndrome. Neurogastroenterol Motil 2003, 15:467-473.
43. Lin HC, Hasler WL Disorders of gastric emptying. Textbook of gastroenterology 1995, 1318-1346. JB Lippincott, Philadelphia, PA. Y. Yamada (Ed.).
44. Parkman H, Miller M, Trate D, et al. Electrogastrography and gastric emptying scintigraphy are complementary for assessment of dyspepsia. J Clin Gastroenterol 1997, 24:214-219.
45. Chial HJ, Camilleri C, Delgado-Aros S, et al. A nutrient drink test to assess maximum tolerated volume and postprandial symptoms. Effects of gender, body mass index, and age in health. Neurogastroenterol Motil 2002, 14:249-253.
46. Koch KL, Xu L, Hong S-P Spectrum of gastric dysrhythmias and gastric emptying in 54 patients with chronic unexplained nausea and vomiting. Gastroenterology 2000, 118(4):A849.
47. Abell TL, Camilleri M, Hench VS, et al. Gastric electromechanical function and gastric emptying in diabetic gastroparesis. Eur J Gastroenterol Hepatology 1991, 3:163-167.
48. Noar MK, Koch KL Effect of radiofrequency ablation on gastric dysrhythmias and gastric emptying in patients with gastroesophageal reflux disease (GERD) and functional dyspepsia. Gastroenterology 2003, 124:A98.
49. Geldof H, Van Der Schee EJ, Van Blankenstein M, et al. Electrogastrographic study of gastric myoelectrical activity in patients with nausea and vomiting. Gut 1986, 27:2799-2808.
50. Boeckxstaens GE, Hirsch DP, Van Locase DEN, et al. Impaired drinking capacity in patients with functional dyspepsia: Relationship with proximal stomach function. Gastroenterology 2001, 121:1054-1063.
51. Tack J, Piessevaux H, Caenepeel P, et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998, 115:1346-1352.
52. Ladabaum U, Koshy SS, Woods ML, et al. Differential symptomatic and electrogastrographic effects of distal and proximal human gastric distention. Am J Physiol 1999, 275:G418-G424.
53. Albibi R, McCallum RW Metoclopramide: pharmacology and clinical application. Ann Intern Med 1983, 98:86-95.
54. Wiseman LR, Faulds D Cisapride: An updated review of its pharmacology therapeutics efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 1994, 47:116-152.
55. Veldhuyzen van Zanten SJO, Jones MJ, Verlinden M, et al. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol 2001, 96:689-696.
56. Brogden RN, Carmine AA, Heel RC, et al. Domperidone: A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic. Drugs 1982, 24:360-400.
57. Patterson DJ, Abell T, Rothstein R, et al. A double-blind multi-center comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol 1999, 93:1230-1234.
58. Janssens J, Peeters TL, Vantrappen G, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. New Engl J Med 1990, 322:1028-1031.
59. Richards RD, Davenport K, McCallum RW The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol 1993, 88:203.
60. Tegaserod Camilleri M. Aliment Pharmacol Ther 2001, 15:277-289.
61. Muller-Lissner SA, Fumagalli I, Bardhan KD, et al. Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 2001, 15:1655-1656.
62. Tougas G, Chen Y, Luo D, et al. Tegaserod improves gastric emptying in patients with gastroparesis and dyspeptic symptoms. Gastroenterology 2003, 124:A54.
63. McKenzie R, Kovac A, O'Connor T, et al. Comparison of ondansetron versus placebo to prevent post-operative nausea and vomiting in women undergoing ambulatory gynecologic surgery. Anesthesiology 1993, 78:21.
64. Muth ER, Jokerst M, Stern RM, et al. Effects of dimenhydrinate on gastric tachyarrhythmia and symptoms of vection-induced motion sickness. Aviat Space Environ Med 1995, 66:1041-1045.
65. Prakash C, Lustman PJ, Freedland KE, et al. Tricyclic antidepressants for functional nausea and vomiting: clinical outcome in 37 patients. Dig Dis Sci 1998, 43:1951-1956.
66. Jednak MA, Shadigian EM, Kim MS, et al. Protein meals reduce nausea and gastric slow wave dysrhythmic activity in first trimester pregnancy. Am J Physiol 1999, 277:G855-G861.
67. Levine ME, Muth ER, Williamson MJ, et al. Protein-predominant meals inhibit development of gastric tachyarrhythmia, nausea in the symptoms of motion sickness. J Aliment Pharmacol Ther 2004, 19:583-590.
68. Dundee GW, Yang J, McMillan C Non-invasive stimulation of the P6 (Neiguan) antiemetic acupuncture point in cancer chemotherapy. JR Soc Med 1991, 84:210-212.
69. Dundee JW, Ghaly RG, Bill KM, et al. Effect of stimulation of the P6 antiemetic point on post-operative nausea and vomiting. Br J Anaesth 1989, 63:612-618.
70. Koch KL, Bingaman S, Xu L, et al. Acute effects of acustimulation at Neiguan point on nausea and gastric myoelectrical activity in patients with chronic nausea. Gastroenterology 1997, 112:A763.
71. Hu S, Stern RM, Koch KL Electrical acustimulation relieves vection-induced motion sickness. Gastroenterology 1992, 102:1854-1858.
72. Evans AT, Samuels SN, Marshall C, et al. Suppression of pregnancy-induced nausea and vomiting with sensory afferent stimulation. J Reproduct Med 1993, 38:603-606.
73. McCallum RW, Chen JD, Lin Z, et al. Gastric pacing improves emptying and symptoms in patients with gastroparesis. Gastroenterology 1998, 114:456-461.
74. Abell T, Hocking M, McCallum R, et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 2003, 125:421-428.
75. Hocking MP, Vogel SB, Sninsky CA Human gastric myoelectrical activity and gastric emptying following gastric surgery and with pacing. Gastroenterology 1992, 103:1821-1826.
76. Mintchev MP, Sanmiguel CP, Amars M, et al. Microprocessor-controlled movement of solid gastric content using sequential neuro-electrical stimulation. Gastroenterology 2000, 118:258-263.
77. Miller LS, Szych GA, Kantor SB, et al. Treatment of idiopathic gastroparesis with injection of Botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol 2002, 97:1653-1660.